Support

Support Options

Submit a Support Ticket

 

Tags: cancer

All Categories (21-40 of 187)

  1. [Illinois] Cancer Community Symposium 2012: Imaging Estrogen Receptors and Estrogen-Receptor Function in Breast Cancer by Positron Emission Tomography (PET): Improved Selection of Patients for Benefit from Endocrine Therapies

    09 May 2012 | Online Presentations | Contributor(s): John A. Katzenellenbogen

    The growth of many breast cancers is regulated by estrogens, and these cancers can be treated effectively with endocrine therapies (ET). Identifying patients who will benefit from ET, however,...

    http://nanohub.org/resources/13950

  2. [Illinois] Cancer Community Symposium 2012: The Man with the Crateriform Lesion: Advanced Squamous Cell Carcinoma

    09 May 2012 | Online Presentations | Contributor(s): Joseph Brancheck

    Cutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer in the United States and accounts for 20 percent of non-melanoma skin cancers; in addition, it is the second...

    http://nanohub.org/resources/13949

  3. [Illinois] Cancer Community Symposium 2012: Speaking Up: The Patient Push for Accelerating Progress in Cancer Research

    09 May 2012 | Online Presentations | Contributor(s): Leslie Hammersmith

    Medical research empowers us to fight cancer, and advocacy empowers us to ensure that it addresses the needs of people affected by cancer. Advocacy helps us get through our cancer experiences,...

    http://nanohub.org/resources/13948

  4. [Illinois] Cancer Community Symposium 2012: Materials Science vs. Metastasis

    09 May 2012 | Online Presentations | Contributor(s): Daniel A. Heller

    Metastasis, the spread of cancer cells from a primary tumor to seed secondary tumors in distant sites, is one of the greatest challenges in cancer treatment today. For many patients, by the time...

    http://nanohub.org/resources/13947

  5. [Illinois] Cancer Community Symposium 2012: Chemical Imaging for Histopathology: An Emerging Route for Molecular and Structural Analysis of Tissues

    09 May 2012 | Online Presentations | Contributor(s): Michael Walsh

    Mid-Infrared (IR) spectroscopic imaging is an emerging approach to derive chemical images from tissues based on their inherent biochemistry. Histologic diagnosis is the gold standard for...

    http://nanohub.org/resources/13946

  6. [Illinois] Cancer Community Symposium 2012: Panel Discussion

    09 May 2012 | Online Presentations

    Please join us for a panel discussion on the social impact of cancer and how it affects patients, providers, clinicians, and researchers alike. We are fortunate to feature Leslie Hammersmith...

    http://nanohub.org/resources/13945

  7. [Illinois] Cancer Community Symposium 2012: Understanding and Targeting Transcription in Hematological Malignancies

    09 May 2012 | Online Presentations | Contributor(s): Jonathan D. Licht

    Abnormalities in the epigenetic regulation of chromatin structure and function can lead to aberrant gene expression and cancer development. Epigenetic regulators can be affected by chromosomal...

    http://nanohub.org/resources/13944

  8. [Illinois] Cancer Community Symposium 2012: The Inhibitory Effects of the Antifibrotic Drug Halofuginone on Uterine Leiomyoma Smooth Muscle Cells

    09 May 2012 | Online Presentations | Contributor(s): Faezeh Koohestani

    Uterine leiomyomas are the most prevalent benign tumors of the reproductive tract in women. Available treatments for leiomyomas are limited to surgical procedures or hormonal therapy, which are...

    http://nanohub.org/resources/13943

  9. [Illinois] Cancer Community Symposium 2012: Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling

    09 May 2012 | Online Presentations | Contributor(s): Elvira de Mejia

    Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling Lunasin is a...

    http://nanohub.org/resources/13942

  10. [Illinois] Cancer Community Symposium 2012: A Sensitivity Scale for Targeting T Cells with Chimeric Antigen Receptors (CAR) and Bispecific T Cell Engagers (BiTE)

    09 May 2012 | Online Presentations | Contributor(s): Jennifer Stone

    Using a patients immune system to target cancer and maintain long-term surveillance is an attractive goal. Although T cells can respond potently to tumors, immune tolerance mechanisms often result...

    http://nanohub.org/resources/13941

  11. [Illinois] Cancer Community Symposium 2012: Micro-western Arrays for Identification of Novel Mechanisms Underlying Resistance of Cancer Cells to Chemotherapeutic Agents

    09 May 2012 | Online Presentations | Contributor(s): Richard B. Jones

    A fundamental goal in cancer treatment is the delivery of therapeutics in a manner that takes into consideration genetic differences between individuals. Genome-wide association analyses have...

    http://nanohub.org/resources/13940

  12. [Illinois] Cancer Community Symposium 2012: DriveRank: Discovering Patient-Specific Driver Mutations

    09 May 2012 | Online Presentations | Contributor(s): Jack Pu Hou

    One of the pressing challenges in cancer genomics is to distinguish driver mutations (i.e. mutations involved in tumorigenesis) and passenger mutations (i.e. functionally neutral mutations)....

    http://nanohub.org/resources/13939

  13. [Illinois] Cancer Community Symposium 2012: Elevated Estrogen Signaling Drives Tumorigenesis in a Novel Animal Model for Ovarian Epithelial Cancer

    09 May 2012 | Online Presentations | Contributor(s): Mary Jo Laws

    We generated a mouse model where aberrant estrogen receptor alpha (Esr1) signaling in the hypothalamo-pituitary-ovarian axis leads to ovarian tumorigenesis. In this model, termed Esr1d/d, the Esr1...

    http://nanohub.org/resources/13938

  14. [Illinois] Cancer Community Symposium 2012: An Integrated Approach to Cancer Research

    09 May 2012 | Online Presentations | Contributor(s): John F. McDonald

    The field of cancer biology is rapidly moving from an era of specialization to an era of integration. In my presentation, I will provide examples of the integration of molecular biology with...

    http://nanohub.org/resources/13937

  15. [Illinois] Cancer Community Symposium 2012: Closing Address and Awards

    09 May 2012 | Online Presentations | Contributor(s): Rohit Bhargava

    Jaeyun Sung announces the awards from the poster sessions. Dr. Rohit Bhargava provides the audience with reflections on the conference and thoughts going forward. Cancer Community At Illinois...

    http://nanohub.org/resources/13936

  16. KIST/PU Advances in detection systems for biology: Classifying signals from fluorescence and scatter

    08 Dec 2011 | Papers | Contributor(s): J. Paul Robinson

    Biology-driven advances in photonic detection systems have been dramatic in the last several years. Three specific aspects are of particular interest: molecular detection, cellular detection, and...

    http://nanohub.org/resources/3789

  17. KIST/PU Nanostructured Heparin Derivatives as an Angiogenesis Inhibitor

    07 Dec 2011 | Online Presentations | Contributor(s): Youngro Byun

    Although low molecular weight heparin (LMWH) has been known to regulate angiogenesis, tumor growth and metastasis, the administration of heparin for treating cancer is limited in clinical...

    http://nanohub.org/resources/12651

  18. KIST/PU 6th Annual Symposium: High Impact Research to Society

    07 Dec 2011 | Workshops

    In 2006, the South Korean Ministry of Science and Technology selected the KIST and Purdue team project from 20 international research proposals submitted to examine how to learn more about the...

    http://nanohub.org/resources/12648

  19. KIST/PU The Professor’s Challenge: To commercialize or not, that is the question?

    06 Dec 2011 | Online Presentations | Contributor(s): J. Paul Robinson

    Outline: Outline the Professors Dilemma Show what the normal criteria for research project direction is Discuss the Corporate perspective Discuss an example of failed innovation Demonstrate...

    http://nanohub.org/resources/12652

  20. KIST/PU Designing a Research Program Around Unmet Clinical Needs

    06 Dec 2011 | Online Presentations | Contributor(s): Alyssa Panitch

    Dr. Panitch specializes in bioorganic chemistry, controlled release and materials and peptide therapeutics. Her research interests include the design and synthesis of biomaterials for drug...

    http://nanohub.org/resources/12650

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.